Bo Xu

144 papers receiving 3.1k citations

Bo Xu's Hit Papers

Programmed Targeting Pyruvate Metabolism Therapy Amplified Single‐Atom Nanozyme‐Activated Pyroptosis for Immunotherapy 2024 · 81 citations
810+1Years since publication255075

Peers

Bo Xu
Comparison fields: 5 of 130
  • Health, Toxicology and Mutagenesis 338
  • Endocrine and Autonomic Systems 130
  • Hepatology 139
  • Immunology 349
  • Cancer Research 224
Replace Jun Watanabe with:
Jun Watanabe Japan
Byung‐Chul Oh South Korea
Qi Cheng China
Quan Fang China
Toshinori Murayama Japan
Francesco Oriente Italy
Shaw‐Fang Yet United States
Richard Siow United Kingdom
Jie Liu China
Noriko Nishimura Japan
Bo Xu relative to Jun Watanabe Japan Jun Watanabe's profile →
Citations per field
00.5×1.5×1.8×
Jun Watanabe · 1×
Citations per year

Countries citing papers authored by Bo Xu

Since Specialization
Citations

This map shows the geographic impact of Bo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Xu more than expected).

Fields of papers citing papers by Bo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Xu. The network helps show where Bo Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Bo Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bo Xu Line = papers co-authored together Bo Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004155
2 2013130
3 201795
4 200893
5 202184
6 200383
7
Programmed Targeting Pyruvate Metabolism Therapy Amplified Single‐Atom Nanozyme‐Activated Pyroptosis for Immunotherapy
Hit paper breakdown →
202481
8 200278
9 200865
10 201164
11 199961
12 202258
13 201556
14 200456
15 201155
16 202154
17 201253
18 202253
19 201553
20 201150

About Bo Xu

Bo Xu is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis and Immunology, having authored 149 papers that have together received 3.1k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (10 papers), Neuroscience of respiration and sleep (7 papers), Heart Rate Variability and Autonomic Control (7 papers), Renal Diseases and Glomerulopathies (5 papers), Advanced Nanomaterials in Catalysis (5 papers), Nanoplatforms for cancer theranostics (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (338 citations), Endocrine and Autonomic Systems (130 citations), Hepatology (139 citations), Immunology (349 citations) and Cancer Research (224 citations). Bo Xu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Martha K. Cathcart, Kaushik P. Patel, Yankai Xia, Gerald M. Feldman, Minjian Chen, Xinru Wang, Hong Zheng, Ashis Bhattacharjee, Xuefei Liu and Biswajit Roy. Their work appears in journals such as BMC Nephrology, Scientific Reports, Nanoscale, BMC Cancer and The Science of The Total Environment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact